Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines - PubMed (original) (raw)

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

Shivakumar Chitturi et al. J Gastroenterol Hepatol. 2007 Jun.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western industrialized countries, affecting 20-40% of the general population. Large population-based surveys in China, Japan, and Korea indicate that the prevalence of NAFLD is now 12% to 24% in population subgroups, depending on age, gender, ethnicity, and location (urban versus rural). There is strong evidence that the prevalence of NAFLD has increased recently in parallel with regional trends in obesity, type 2 diabetes, and metabolic syndrome; and that further increases are likely. The relationship between NAFLD, central obesity, diabetes, and metabolic syndrome is clearly evident in retrospective and prospective Asian studies, but the strength of association with these metabolic risk factors is only appreciated when regional definitions of anthropometry are used. Pathological definition of NAFLD, particularly its activity and the extent of liver fibrosis, requires histological examination, but liver biopsy is often not appropriate in this disorder for logistic reasons. An alternative set of operational definitions is proposed here. Clinicians need guidelines as how best to diagnose and manage NAFLD and its associated metabolic disorders in countries with scant healthcare resources. The Asia-Pacific Working Party (APWP) for NAFLD was convened to collate evidence and deliberate these issues. Draft proposals were presented and discussed at Asia-Pacific Digestive Week at Cebu, Philippines, in late November 2006, and are published separately in this issue of the Journal as an Executive Summary. The present document reviews the reasoning and evidence behind the APWP-NAFLD proposals for definition, assessment, and management of NAFLD in the Asia-Pacific region.

PubMed Disclaimer

Comment in

Non-alcoholic fatty liver disease guidelines: an Asian perspective.
Ishii H, Kajihara M. Ishii H, et al. J Gastroenterol Hepatol. 2007 Jun;22(6):769-70. doi: 10.1111/j.1440-1746.2007.05015.x. J Gastroenterol Hepatol. 2007. PMID: 17565626 No abstract available.
Should we stop "MaS"ing about with steatotic liver grafts and "MiS" out on potential donor livers?
Teoh NC. Teoh NC. J Gastroenterol Hepatol. 2012 Mar;27(3):422-4. doi: 10.1111/j.1440-1746.2012.07061.x. J Gastroenterol Hepatol. 2012. PMID: 22353348 No abstract available.

Cited by

Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis.
Hamano M, Ezaki H, Kiso S, Furuta K, Egawa M, Kizu T, Chatani N, Kamada Y, Yoshida Y, Takehara T. Hamano M, et al. J Gastroenterol. 2014 Feb;49(2):305-16. doi: 10.1007/s00535-013-0780-7. Epub 2013 Mar 20. J Gastroenterol. 2014. PMID: 23512345 Free PMC article.
Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Kishida N, Matsuda S, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Hibi T, Masugi Y, Aiura K, Sakamoto M, Kitagawa Y. Kishida N, et al. BMC Gastroenterol. 2016 Jun 13;16(1):61. doi: 10.1186/s12876-016-0477-5. BMC Gastroenterol. 2016. PMID: 27296438 Free PMC article.
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
Farrell GC, van Rooyen D, Gan L, Chitturi S. Farrell GC, et al. Gut Liver. 2012 Apr;6(2):149-71. doi: 10.5009/gnl.2012.6.2.149. Epub 2012 Apr 17. Gut Liver. 2012. PMID: 22570745 Free PMC article.
Establishment of a novel non‑alcoholic fatty liver disease model using cholesterol‑fed rabbits with reference to the potential role of endoplasmic reticulum stress.
Wang Y, Zhang P, Su X, Yu Q, Chen Y, Guan H, Liu E, Fan J. Wang Y, et al. Mol Med Rep. 2018 Sep;18(3):2898-2904. doi: 10.3892/mmr.2018.9258. Epub 2018 Jul 6. Mol Med Rep. 2018. PMID: 30015906 Free PMC article.
Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM, Kavanagh TJ, Fausto N. Haque JA, et al. Lab Invest. 2010 Dec;90(12):1704-17. doi: 10.1038/labinvest.2010.112. Epub 2010 Jun 14. Lab Invest. 2010. PMID: 20548286 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines - PubMed (original) (raw)